OX2 Receptors – mTOR inhibitor Combined with Irradiation Reduces resistant breast cancer

Proof applicability was shown for just two therapeutic molecule classes and two relevant functional testing read-outs

October 24, 2024

Regulated degradation of CPH1 driven that it had been needed for growth in vitro